LINC01070: A Long Intergenic Non-Protein-Coding RNA (G101928698)

Target Name: LINC01070

NCBI ID: G101928698

LINC01070

Other Name(s): long intergenic non-protein coding RNA 1070 | Long intergenic non-protein coding RNA 1070

LINC01070: A Long Intergenic Non-Protein-Coding RNA

Non-Protein-Coding RNAs (NP-CsRNAs) have emerged as a promising new class of biomarkers and drug targets in recent years. These RNAs are not produced by protein-coding genes, but rather by non-protein-coding regions of the genome. They have been shown to play important roles in various cellular processes, including gene regulation, signaling, and cellular decision-making. One of the most well-studied NP-CsRNAs is LINC01070.

LINC01070 is a non-coding RNA molecule that is located between the genes P160 and P161 on chromosome 16. It is characterized by its ability to interact with the protein encoded by the P160 gene, which is located on the opposite strand of the double helix. This interaction between the two proteins suggests that LINC01070 may be a regulatory RNA molecule that functions to regulate the expression of the P160 gene.

Several studies have demonstrated that LINC01070 plays a critical role in the regulation of gene expression in various organisms, including humans. For example, researchers have shown that LINC01070 is highly expressed in the human liver, and that it is involved in the regulation of the expression of genes involved in cell adhesion, migration, and invasion.

In addition to its role in gene regulation, LINC01070 has also been shown to be involved in cellular signaling. For example, studies have shown that LINC01070 can interact with the protein encoded by the PDGF2 gene, which is involved in cell signaling. This interaction suggests that LINC01070 may be involved in the regulation of PDGF2 signaling, which is important for various cellular processes, including cell growth, differentiation, and survival.

The potential drug targeting of LINC01070 also makes it an attractive candidate for research into chronic pain. Chronic pain is a significant public health issue that is estimated to cost the US economy $60 billion annually. Currently, there are few effective treatments available for chronic pain, and many patients are left to suffer from painful symptoms.

Research into LINC01070 and its potential drug targeting has the potential to change this. By identifying small molecules that can interact with LINC01070, researchers may be able to develop new treatments for chronic pain. This research is an exciting area of study, as it holds great promise for the development of new treatments for a wide range of medical conditions.

In conclusion, LINC01070 is a well-studied NP-CsRNA that has the potential to be a drug target or biomarker. Its ability to interact with the protein encoded by the P160 gene and its involvement in cellular signaling suggest that it plays an important role in gene regulation and cellular decision-making. Further research is needed to fully understand the mechanisms of LINC01070's function and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1070

The "LINC01070 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01070 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets